Cargando…

Corrigendum to “Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG oncology study (NRG-GY008)” [Gynecol. Oncol. Rep. 31 (2020) 100532]

Detalles Bibliográficos
Autores principales:	Santin, Alessandro D., Filiaci, Virginia, Bellone, Stefania, O'Cearbhaill, Roisin, Ratner, Elena S., Mathews, Cara A., Cantuaria, Guilherme, Gunderson, Camille C., Rutledge, Teresa, Buttin, Barbara M., Lankes, Heather A., Birrer, Michael J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452617/ https://www.ncbi.nlm.nih.gov/pubmed/32885014 http://dx.doi.org/10.1016/j.gore.2020.100590

Ejemplares similares

Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG Oncology study (NRG-GY008)
por: Santin, Alessandro D., et al.
Publicado: (2020)

Effects of RET, NRG1 and NRG3 Polymorphisms in a Chinese Population with Hirschsprung Disease
por: Yang, Dehua, et al.
Publicado: (2017)

NRG-1 talks back to neurons
por: LeBrasseur, Nicole
Publicado: (2003)

NRG1 fusions in breast cancer
por: Howarth, Karen D., et al.
Publicado: (2021)

Back signaling by the Nrg-1 intracellular domain
por: Bao, Jianxin, et al.
Publicado: (2003)

Novel molecular changes induced by Nrg1 hypomorphism and Nrg1-cannabinoid interaction in adolescence: a hippocampal proteomic study in mice
por: Spencer, Jarrah R., et al.
Publicado: (2013)

Identification of Novel CDH1-NRG2α and F11R-NRG2α Fusions in NSCLC Plus Additional Novel NRG2α Fusions in Other Solid Tumors by Whole Transcriptome Sequencing
por: Ou, Sai-Hong Ignatius, et al.
Publicado: (2020)

Fine Mapping of the NRG1 Hirschsprung's Disease Locus
por: Tang, Clara Sze-Man, et al.
Publicado: (2011)

NRG1 variant effects in patients with Hirschsprung disease
por: Gunadi, et al.
Publicado: (2018)

Nrg1 Intracellular Signaling Is Neuroprotective upon Stroke
por: Navarro-González, Carmen, et al.
Publicado: (2019)

Expression of NRG1 and its receptors in human bladder cancer
por: Forster, J A, et al.
Publicado: (2011)

Cell Surface Expression of Nrg1 Protein in Candida auris
por: Paudyal, Anuja, et al.
Publicado: (2021)

The impact of NRG1 expressions and methylation on multifactorial Hirschsprung disease
por: Gunadi, et al.
Publicado: (2022)

Association of Radiotherapy Duration With Clinical Outcomes in Patients With Esophageal Cancer Treated in NRG Oncology Trials: A Secondary Analysis of NRG Oncology Randomized Clinical Trials
por: Hallemeier, Christopher L., et al.
Publicado: (2023)

Comprehensive Analysis of NRG1 Common and Rare Variants in Hirschsprung Patients
por: Luzón-Toro, Berta, et al.
Publicado: (2012)

NRG Oncology Survey on Practice and Technology Use in SRT and SBRT Delivery
por: Chetvertkov, Mikhail, et al.
Publicado: (2020)

Comparison of maternal serum NRG-4 levels in healthy and preeclamptic pregnancies
por: Yakut, Kadriye, et al.
Publicado: (2022)

Nrg1 Regulates Cardiomyocyte Migration and Cell Cycle in Ventricular Development
por: Grego-Bessa, Joaquim, et al.
Publicado: (2023)

Changes of neuregulin-1(NRG-1) expression in a rat model of overactive bladder induced by partial urethral obstruction: is NRG-1 a new biomarker of overactive bladder?
por: Jang, Hoon, et al.
Publicado: (2013)

Corrigendum to “Metastatic hepatoid carcinoma of ovarian origin - A case report from Northern Pakistan” [Gynecol. Oncol. Rep. 21 (2017) 24–27]
por: Mahmood, Humera, et al.
Publicado: (2017)

Angiotensin II inhibits apoptosis of mouse aortic smooth muscle cells through regulating the circNRG-1/miR-193b-5p/NRG-1 axis
por: Sun, Yan, et al.
Publicado: (2019)

Final survival analysis of topotecan and paclitaxel for first-line treatment of advanced cervical cancer: An NRG oncology randomized study
por: Tewari, Krishnansu S., et al.
Publicado: (2023)

NRG1 fusion in a French cohort of invasive mucinous lung adenocarcinoma
por: Duruisseaux, Michaël, et al.
Publicado: (2016)

T186. ASSOCIATION BETWEEN POLYMORPHISMS OF THE NEUREGULIN 1 (NRG1) GENE AND SCHIZOPHRENIA
por: Xu, Junzhe, et al.
Publicado: (2018)

Effects of NRG1 Polymorphisms on Hirschsprung’s Disease Susceptibility: A Meta-analysis
por: Jiang, Meng, et al.
Publicado: (2017)

Increased NRG1-ErbB4 signaling in human symptomatic epilepsy
por: Zhu, Jun-Ming, et al.
Publicado: (2017)

Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer
por: Zhang, Zeda, et al.
Publicado: (2020)

Acid pH Strategy Adaptation through NRG1 in Ustilago maydis
por: Sánchez-Arreguin, José Alejandro, et al.
Publicado: (2021)

NRG4-ErbB4 signaling represses proinflammatory macrophage activity
por: Schumacher, Michael A., et al.
Publicado: (2021)

Cartilage regeneration in zebrafish depends on Nrg1/ErbB signaling pathway
por: Sapède, Dora, et al.
Publicado: (2023)

Clinicopathological Characteristics of NRG1 Fusion–Positive Solid Tumors in Korean Patients
por: Cha, Yoon Jin, et al.
Publicado: (2023)

Letter to Editor in response to “Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons” by Bakkum-Gamez et al. (Gynecol Oncol. 2015)
por: Fambrini, Massimiliano, et al.
Publicado: (2015)

Improving Risk Assessment for Metastatic Disease in Endometrioid Endometrial Cancer Patients Using Molecular and Clinical Features: An NRG Oncology/Gynecologic Oncology Group Study
por: Casablanca, Yovanni, et al.
Publicado: (2022)

An international randomized phase III trial of pulse actinomycin-D versus multi-day methotrexate for the treatment of low risk gestational trophoblastic neoplasia; NRG/GOG 275
por: Schink, Julian C., et al.
Publicado: (2020)

NRG1 is required for glucose repression of the SUC2 and GAL genes of Saccharomyces cerevisiae
por: Zhou, Heng, et al.
Publicado: (2001)

Nrg1 is an injury-induced cardiomyocyte mitogen for the endogenous heart regeneration program in zebrafish
por: Gemberling, Matthew, et al.
Publicado: (2015)

Transcriptional fingerprinting of “browning” white fat identifies NRG4 as a novel adipokine
por: Christian, Mark
Publicado: (2014)

Spironolactone is an antagonist of NRG1‐ERBB4 signaling and schizophrenia‐relevant endophenotypes in mice
por: Wehr, Michael C, et al.
Publicado: (2017)

Peripheral Transcription of NRG-ErbB Pathway Genes Are Upregulated in Treatment-Resistant Schizophrenia
por: Mostaid, Md Shaki, et al.
Publicado: (2017)

Recruitment practices for U.S. minority and underserved populations in NRG oncology: Results of an online survey()
por: Cook, Elise D., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_n8kd15ck3qh6ve54og98j9cebs